Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Safety and Immunogenicity of a Serogroups A/C Neisseria meningitidis Oligosaccharide—Protein Conjugate Vaccine in Young Children

15 May 1996

Abstract excerpt

OBJECTIVE: To assess the safety and immunogenicity of a bivalent serogroups A/C meningococcal oligosaccharide-protein conjugate vaccine compared with the licensed meningococcal polysaccharide vaccine. DESIGN: Randomized controlled trial. STUDY POPULATION: Ninety healthy 18- to 24-month-old children who were seen at a southern California Kaiser Permanente clinic. INTERVENTIONS: Vaccination with either the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bacterial Infections and Vaccines
Share to Pneumonia and Respiratory Infections
Share to Virology and Viral Diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 8622225
DOI: 10.1001/jama.1996.03530430043037

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Safety and Immunogenicity of a Serogroups A/C Neisseria meningitidis Oligosaccharide—Protein Conjugate Vaccine in Young ChildrenPMID 8622225Read ↗

Polysaccharide Conjugate Vaccines: From Historical Milestones to Future StrategiesSemantic proximity Read ↗

Immunogenicity and Safety of a Meningococcal A Conjugate Vaccine in AfricansSemantic proximity Read ↗

Meningococcal serogroup B vaccines: Estimating breadth of coverageSemantic proximity Read ↗

Meningococcal protein antigens and vaccinesSemantic proximity Read ↗

Meningococcal Serogroup ACWYX Conjugate Vaccine in Malian ToddlersSemantic proximity Read ↗

The Development of a Vaccine Against Meningococcus B Using Reverse VaccinologySemantic proximity Read ↗

Meningococcal Serogroup B Bivalent rLP2086 Vaccine Elicits Broad and Robust Serum Bactericidal Responses in Healthy AdolescentsSemantic proximity Read ↗

Immunogenicity of Two Investigational Serogroup B Meningococcal Vaccines in the First Year of LifeSemantic proximity Read ↗

Identification of Vaccine Candidates Against Serogroup B Meningococcus by Whole-Genome SequencingSemantic proximity Read ↗

A combination recombinant protein and outer membrane vesicle vaccine against serogroup B meningococcal diseaseSemantic proximity Read ↗

A Bivalent Meningococcal B Vaccine in Adolescents and Young AdultsSemantic proximity Read ↗

Correlates of protection for meningococcal surface protein vaccines: lessons from the pastSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.